Noble metal complexes in cancer chemotherapy
- PMID: 343531
- DOI: 10.1007/978-1-4684-0796-9_10
Noble metal complexes in cancer chemotherapy
Abstract
Platinum coordination complexes form a new class of active anticancer agents in animals and man. Cis-dichlorodiammineplatinum (II), the most widely investigated drug, is now in experimental clinical use against a wide variety of cancers in man. The dose-limiting toxicity in man is renal tubular damage. Hydration of the patient and the use of osmotic diuretics have minimized this effect and allowed higher doses with largely improved responses. Combination chemotherapy with the drug has also produced significant response rates in a variety of cancers. The mode of action of the drug is not yet clear, but most likely involves a primary lesion on nuclear DNA and the stimulation of a host reaction to the cancer. So far, only square planar and octahedral complexes of platinum, with a variety of inorganic and organic ligands, have shown marked activity in animal studies.
Similar articles
-
Platinum coordination complexes in cancer chemotherapy.Naturwissenschaften. 1973 Sep;60(9):399-406. doi: 10.1007/BF00623551. Naturwissenschaften. 1973. PMID: 4203933 Review. No abstract available.
-
cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1459-73. Cancer Treat Rep. 1979. PMID: 291480
-
Pharmacology and clinical applications of cis-platinum.Urology. 1985 Feb;25(2):155-60. doi: 10.1016/0090-4295(85)90533-3. Urology. 1985. PMID: 3881872 Review.
-
Comparative adverse effect profiles of platinum drugs.Drug Saf. 1995 Oct;13(4):228-44. doi: 10.2165/00002018-199513040-00003. Drug Saf. 1995. PMID: 8573296 Review.
-
Platinum compounds in cancer chemotherapy.Biochem Exp Biol. 1980;16(2):191-212. Biochem Exp Biol. 1980. PMID: 6753877 Review. No abstract available.
Cited by
-
Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.Molecules. 2022 Aug 25;27(17):5434. doi: 10.3390/molecules27175434. Molecules. 2022. PMID: 36080200 Free PMC article.
-
Design, Synthesis, and Targeted Delivery of Fluorescent 1,2,4-Triazole-Peptide Conjugates to Pediatric Brain Tumor Cells.ACS Omega. 2019 Dec 18;4(27):22280-22291. doi: 10.1021/acsomega.9b01903. eCollection 2019 Dec 31. ACS Omega. 2019. PMID: 31909311 Free PMC article.
-
Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.J Pain. 2009 May;10(5):534-41. doi: 10.1016/j.jpain.2008.12.003. Epub 2009 Feb 23. J Pain. 2009. PMID: 19231296 Free PMC article.
-
Circumventing tumor resistance to chemotherapy by nanotechnology.Methods Mol Biol. 2010;596:467-88. doi: 10.1007/978-1-60761-416-6_21. Methods Mol Biol. 2010. PMID: 19949937 Free PMC article.
-
Cis-platinum: a new anticancer agent.Br Med J. 1979 Jun 23;1(6179):1689-91. doi: 10.1136/bmj.1.6179.1689. Br Med J. 1979. PMID: 380759 Free PMC article. Review. No abstract available.